Chi Van Dang
Scientific Director, Ludwig Institute for Cancer Research; Professor, Wistar Institute
Meet Chi Van Dang
“As a biomedical researcher, the emergence of immunotherapies for cancer patients has provided me and others across the industry with such opportunities. The tangible impact on clinical outcomes of these treatments is evident. However, we are still challenged by why many patients don’t have durable responses and additional research will be critical to overcoming this barrier and achieving more cancer cures.”